Statistics for A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.

Total visits

views
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation. 182

Total visits per month

views
October 2023 1
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0

File Visits

views
Arai_Sarantopoulos_CCR_2016_imatinib study.pdf 177

Top country views

views
Germany 37
United Kingdom 24
United States 17
South Korea 6
China 4
Singapore 4
France 1
Indonesia 1
Netherlands 1

Top city views

views
Kiez 22
Alexandria 7
Changi 4
Woodbridge 3
Beijing 2
Little Rock 2
Seoul 2
Suzhou 2
Winsted 2
Buffalo 1
Durham 1
Mountain View 1
Norwalk 1
Old Bridge 1
Overland Park 1
Seattle 1
Southampton 1
Yulee 1